Optimizing Gastroenterology Prior Authorization Automation

High-Volume PA Categories in Gastroenterology

Prior authorization in GI concentrates heavily on chronic conditions and advanced diagnostics. This includes high-cost biologics such as Humira, Stelara, Skyrizi, and Entyvio for IBD, which often require periodic re-authorization. Advanced imaging like MRCP and MR enterography, alongside specific endoscopic procedures such as capsule endoscopy (CPT 91110) and ERCP, also frequently trigger PA requirements. Klivira’s system is configured to identify and manage these high-volume, high-value PA triggers at the point of order entry.

Navigating Complex GI Documentation Requirements

Successful GI prior authorizations hinge on precise documentation aligned with clinical guidelines from bodies like ACG, AGA, and AASLD. For IBD biologics, this means confirming diagnosis, documenting disease severity (e.g., Mayo score for UC, CDAI for Crohn's), and substantiating step therapy compliance. Hepatitis C direct-acting antivirals (DAAs) require genotype, fibrosis stage, and prior-treatment history. Klivira automates the discovery and assembly of this critical clinical data from the EMR, minimizing manual chart pulls and documentation gaps.

Klivira's Automated GI Prior Authorization Workflow

• **EMR-Integrated PA Detection:** Using CDS Hooks, Klivira identifies PA requirements for GI orders at the point of entry in systems like Epic and Cerner, preventing missed authorizations.
• **Automated Documentation Assembly:** The platform leverages FHIR resources (e.g., MedicationRequest, DiagnosticReport) to compile payer-specific documentation packets, including disease severity scores and prior-therapy trials.
• **Intelligent Payer Submission Routing:** Klivira routes requests via optimal channels, prioritizing Da Vinci PAS APIs, X12 278 EDI, or provider portal APIs, with fax fallback for less-digital payers.
• **Real-Time Status Tracking & Write-Back:** Automated polling and webhook integration provide continuous status updates, writing authorization numbers back to the EMR upon approval, ensuring claims accuracy.
• **Streamlined Denial & Appeal Management:** Klivira parses denial reasons, routes cases for human review or auto-appeal, and manages timely-filing windows for comprehensive appeal automation.

Addressing GI-Specific Workflow Constraints

Gastroenterology presents unique PA challenges, including the ongoing re-authorization burden for chronic IBD biologic treatments and the variability in biosimilar substitution policies across payers. The medical-vs-pharmacy benefit split for biologics, and the critical distinction between treatment-naive vs. treatment-experienced patients for both IBD and Hep C DAAs, further complicate workflows. Klivira’s policy engine accounts for these nuances, automating re-authorization schedules, managing benefit-side changes, and accurately classifying patient treatment status to ensure correct PA pathways are followed.

Impact on Revenue Cycle and Patient Access

By automating gastroenterology prior authorization, Klivira significantly reduces administrative overhead and accelerates decision times. This translates to fewer claims denials, improved revenue capture, and enhanced patient satisfaction through faster access to necessary treatments and procedures. Our platform helps GI practices meet the increasing demands of payer policies while maintaining focus on patient care, aligning with industry benchmarks from sources like the CAQH Index on the cost-effectiveness of electronic PA.